Fordyce Marshall (CIK 1859453) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-24). Recent activity: Sell VERA (88 shares), Sell VERA (18,412 shares), Sell VERA (14,219 shares), Sell VERA (4,281 shares), Sell VERA (14,130 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-24 | Vera Therapeutics, Inc. (VERA) | PRESIDENT AND CEO | Sell | 88 | $3,382 |
| 2026-06-24 | Vera Therapeutics, Inc. (VERA) | PRESIDENT AND CEO | Sell | 18,412 | $698,387 |
| 2026-05-13 | Vera Therapeutics, Inc. (VERA) | PRESIDENT AND CEO | Sell | 14,219 | $520,978 |
| 2026-05-13 | Vera Therapeutics, Inc. (VERA) | PRESIDENT AND CEO | Sell | 4,281 | $158,769 |
| 2026-04-15 | Vera Therapeutics, Inc. (VERA) | PRESIDENT AND CEO | Sell | 14,130 | $616,985 |
| 2026-04-15 | Vera Therapeutics, Inc. (VERA) | PRESIDENT AND CEO | Sell | 7,921 | $353,106 |
| 2026-04-15 | Vera Therapeutics, Inc. (VERA) | PRESIDENT AND CEO | Sell | 900 | $40,960 |
| 2026-02-25 | Vera Therapeutics, Inc. (VERA) | PRESIDENT AND CEO | Sell | 16,925 | $710,512 |
| 2026-02-06 | Vera Therapeutics, Inc. (VERA) | PRESIDENT AND CEO | Buy | 68,800 | $0 |
| 2025-02-27 | Vera Therapeutics, Inc. (VERA) | PRESIDENT AND CEO | Sell | 10,613 | $295,997 |
| 2025-02-27 | Vera Therapeutics, Inc. (VERA) | PRESIDENT AND CEO | Sell | 7,975 | $219,711 |
| 2025-02-27 | Vera Therapeutics, Inc. (VERA) | PRESIDENT AND CEO | Sell | 1,100 | $31,152 |
| 2025-02-20 | Vera Therapeutics, Inc. (VERA) | PRESIDENT AND CEO | Buy | 80,750 | $0 |
Source: SEC Form 4 filings · as of 2026-06-24